GlassScriptPhysician profile
Jennifer N Thompson
NPI 1982246229
$2,470.88
in general payments reported to CMS, 2019-2025
20 companies · $647 in 2025
The $647 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $450 · 2022: $432 · 2023: $422 · 2024: $520 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $715.76 | 2021-2025 | Proclaim |
| Boston Scientific Corporation | $369.71 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $312.47 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $242.71 | 2023-2025 | Xtampza, Belbuca, Jornay Pm |
| Abbvie INC. | $178.81 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $137.33 | 2024-2025 | Relistor, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $103.45 | 2022 | |
| Idorsia Pharmaceuticals US INC | $81.46 | 2023-2024 | Quviviq |
| Scilex Pharmaceuticals INC. | $58.16 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $48.95 | 2025 | |
| Lundbeck LLC | $41.86 | 2025 | Vyepti |
| Spinal Simplicity, LLC | $25.48 | 2025 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $25.00 | 2025 | Evoke |
| Relievant Medsystems, INC. | $25.00 | 2023 | Intracept |
| Stryker Corporation | $20.83 | 2024 | Mild Device Kit |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $18.62 | 2023 | Painteq |
| Spr Therapeutics, INC | $17.76 | 2025 | Sprint Pns System |
| Hikma Pharmaceuticals USA | $16.58 | 2022 | |
| Celgene Corporation | $15.75 | 2022 | |
| Lilly USA, LLC | $15.19 | 2023 | Reyvow, Emgality |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.